Home›People›Chad Waite
CW

Chad Waite

Board Member at Cyrus Biotechnology.

Director
Updated Nov 10, 2026·Latest SEC filing May 8, 2026·Suggest an edit

About Chad Waite

Chad Waite is a board member at Cyrus Biotechnology.

Chad Waite first appears on SEC filings in 2017.

Experience

This experience comes from SEC filings. The years are when the filings name Chad Waite in the role, so the role may have started earlier or lasted longer.

Cyrus Biotechnology, Inc.
Board Member
2017 – 2026 · Seattle, WA
Develops protein-based drug candidates for its own pipeline and biotechnology and pharmaceutical partners.

Key Colleagues at Startups

The people Chad Waite works with at each company, as listed on that company's latest Form D.

Cyrus Biotechnology, Inc. · Form D/A, May 8, 2026
Yifan Song
Yifan Song
Chief Technology Officer and director
JS
Jason Smith
Board Member
Mark Benjamin
Mark Benjamin
President and EVP Business Development
Lucas Nivon
Lucas Nivon
Chief Executive Officer and director
AM
Anthony Manning
Board Member

Sources

  1. SECCyrus Biotechnology, Inc. Form D/A, filed May 8, 2026